GSM1606796[Accession] - GEO DataSets

Warning: The NCBI web site requires JavaScript to function. more...

Format

Summary
Summary (text)
Unique Identifier List

Sort by

Default order
Number of Samples (High to Low)
Number of Samples (Low to High)

Send to:

Choose Destination

File
Clipboard
Collections

Search results

Items: 4

Select item 2000658211.

Whole genome characterisation of chemoresistant ovarian cancer

(Submitter supplied) This SuperSeries is composed of the SubSeries listed below. Patients with high-grade serous ovarian cancer (HGSC) have experienced little improvement in overall survival, and standard treatment has not advanced beyond platinum-based combination chemotherapy, during the past 30 years. To understand the drivers of clinical phenotypes better, here we use whole-genome sequencing of tumour and germline DNA samples from 92 patients with primary refractory, resistant, sensitive and matched acquired resistant disease. more...

Organism:: Homo sapiens

Type:: Non-coding RNA profiling by array; Methylation profiling by genome tiling array; Genome variation profiling by SNP array

4 related Platforms
356 Samples

Download data: CSV, IDAT, TXT

Series

Accession:: GSE65821

ID:: 200065821

Select item 2000658192.

Whole genome characterisation of chemoresistant ovarian cancer [NanoString miRNA]

(Submitter supplied) Patients with high-grade serous ovarian cancer (HGSC) have experienced little improvement in overall survival, and standard treatment has not advanced beyond platinum-based combination chemotherapy, during the past 30 years. To understand the drivers of clinical phenotypes better, here we use whole-genome sequencing of tumour and germline DNA samples from 92 patients with primary refractory, resistant, sensitive and matched acquired resistant disease. more...